Anixa Biosciences, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Anixa Biosciences, Inc. now
Current reporting with the operating signal separated from the noise.
Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript
Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript
The story matters when it changes Anixa Biosciences, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ANIX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
10-QQuarterly financial reportFiled 2026-06-10 · Period 2026-04-30SEC ↗10-QQuarterly financial reportFiled 2026-03-09 · Period 2026-01-31SEC ↗10-KAnnual financial reportFiled 2026-01-12 · Period 2025-10-31SEC ↗8-KMaterial company eventFiled 2026-03-11 · Period 2026-03-10SEC ↗8-KMaterial company eventFiled 2026-02-09 · Period 2026-02-09SEC ↗8-KMaterial company eventFiled 2025-12-12 · Period 2025-12-11SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-01-28 · Period 2026-01-28SEC ↗4Official SEC filingFiled 2026-08-03 · Period 2026-07-31SEC ↗
Anixa Biosciences, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →